항균제 내성 감시 시장 분석 및 예측 : 유형, 제품 유형, 서비스, 기술, 구성 요소, 용도, 최종 사용자, 솔루션, 도입 형태(-2035년)

Antimicrobial Resistance Surveillance Market is anticipated to expand from $9.5 billion in 2024 to $15.3 billion by 2034, growing at a CAGR of approximately 4.9%. The Antimicrobial Resistance Surveillance Market encompasses systems and methodologies for monitoring and analyzing resistance patterns in pathogens. This market includes data collection, laboratory testing, and reporting tools essential for public health and pharmaceutical strategies. With rising antimicrobial resistance, demand is increasing for advanced surveillance technologies that enable timely interventions and policy-making. The market is driven by the need for global collaboration and innovation in diagnostic tools and data analytics to effectively combat resistance trends.

The Antimicrobial Resistance (AMR) Surveillance Market is experiencing robust growth, propelled by the urgent need to combat antibiotic-resistant pathogens. The diagnostic devices segment leads in performance, with rapid diagnostic tests and next-generation sequencing technologies playing pivotal roles. These technologies enable swift identification of resistant strains, crucial for effective treatment strategies. The software and services segment follows closely, driven by the increasing adoption of data analytics platforms and cloud-based surveillance systems. These tools facilitate real-time data sharing and predictive analytics, enhancing global surveillance efforts. Within the diagnostic devices sub-segment, point-of-care testing devices are emerging as top performers, offering convenience and speed in diverse healthcare settings. Laboratory-based diagnostic devices are anticipated as the second highest-performing sub-segment, given their accuracy and comprehensive testing capabilities. The rising prevalence of AMR and the need for coordinated global responses underscore the importance of these advancements, presenting lucrative opportunities for stakeholders in this critical market.

Market Snapshot:

Antimicrobial Resistance Surveillance Market is witnessing a dynamic shift with significant strides in market share, pricing, and new product launches. The market is characterized by innovative surveillance solutions that cater to the burgeoning demand for effective antimicrobial resistance monitoring. Key players are strategically launching advanced products, enhancing their portfolios to meet evolving consumer needs. The pricing landscape is competitive, with companies leveraging cost-effective strategies to gain a competitive edge. The market's growth is underpinned by the increasing prevalence of antimicrobial resistance, driving the need for robust surveillance systems. The competitive landscape is marked by intense rivalry among leading firms, with a strong emphasis on technological innovation and strategic collaborations. Regulatory influences play a pivotal role, with stringent guidelines shaping market dynamics and ensuring compliance. North America and Europe are at the forefront, driven by sophisticated healthcare infrastructures and supportive regulatory frameworks. The Asia-Pacific region is emerging as a lucrative market, propelled by rising healthcare investments and awareness initiatives. The market's future is promising, with advancements in molecular diagnostics and real-time data analytics poised to drive substantial growth.

Geographical Overview:

The Antimicrobial Resistance (AMR) Surveillance Market is witnessing significant expansion across diverse regions, each presenting unique growth opportunities. North America remains at the forefront, propelled by robust healthcare infrastructure and increased governmental initiatives to combat AMR. The region's focus on advanced technologies and data integration further accelerates market development. Europe is closely following, benefitting from strong regulatory frameworks and collaborative efforts among nations to address AMR challenges. In Asia Pacific, the market is experiencing rapid growth, driven by rising healthcare investments and the increasing burden of AMR. Countries like India and China are emerging as pivotal players, with substantial investments in surveillance systems and public health initiatives. Latin America and the Middle East & Africa are also witnessing growing potential. In Latin America, increased awareness and healthcare funding are fostering market expansion, while the Middle East & Africa are focusing on strengthening health systems to address AMR effectively.

Key Trends and Drivers:

The Antimicrobial Resistance (AMR) Surveillance Market is experiencing robust growth due to heightened awareness of AMR's global health threat. Key trends include the integration of advanced data analytics and artificial intelligence to enhance surveillance capabilities. This technological evolution is enabling more precise tracking of resistance patterns and facilitating timely interventions. Governments and international organizations are increasingly investing in AMR surveillance infrastructure, recognizing the critical need for coordinated efforts. The rise of public-private partnerships is fostering innovation and resource sharing, further propelling market development. Additionally, the growing prevalence of multi-drug resistant infections is driving demand for comprehensive surveillance solutions. The market is also influenced by the expansion of healthcare infrastructure in emerging economies, which are prioritizing AMR initiatives. Opportunities abound for companies offering scalable and cost-effective surveillance technologies. As global health policies continue to emphasize AMR mitigation, the market is poised for sustained growth, with significant potential in regions with burgeoning healthcare needs.

Restraints and Challenges:

The Antimicrobial Resistance Surveillance Market encounters several significant restraints and challenges. A primary challenge is the high cost of implementing sophisticated surveillance systems, which hampers adoption in low-income countries and smaller healthcare facilities. Many institutions still rely on outdated methods, leading to inconsistent data and inadequate monitoring of resistance patterns. Moreover, there is a pervasive lack of awareness and education about the importance of antimicrobial resistance surveillance, which diminishes its perceived value. In several regions, insufficient government funding and support further inhibit market expansion. Additionally, the complexity of resistance mechanisms necessitates specialized expertise, which is often scarce, complicating data analysis and interpretation. The market also faces challenges related to data sharing and integration across different platforms and regions, which restricts comprehensive surveillance efforts. Furthermore, logistical issues, such as timely data collection and transmission, can cause delays, reducing the efficacy of resistance tracking. These factors collectively impede the growth and effectiveness of the antimicrobial resistance surveillance market.

Key Players:

bioMerieux, Thermo Fisher Scientific, Luminex Corporation, Alere Inc, OpGen, Accelerate Diagnostics, Meridian Bioscience, T2 Biosystems, Mobidiag, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, Bruker Corporation, Qiagen, Abbott Laboratories

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Solutions
• 2.9 Key Market Highlights by Deployment

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Pathogen-specific Surveillance
  • 4.1.2 Drug-specific Surveillance
  • 4.1.3 Laboratory-based Surveillance
  • 4.1.4 Community-based Surveillance
  • 4.1.5 Hospital-based Surveillance
  • 4.1.6 Veterinary Surveillance
  • 4.1.7 Environmental Surveillance
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Software
  • 4.2.2 Databases
  • 4.2.3 Reagents
  • 4.2.4 Instruments
  • 4.2.5 Consumables
  • 4.2.6 Kits
  • 4.2.7 Assays
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Data Management
  • 4.3.2 Consulting
  • 4.3.3 Training and Education
  • 4.3.4 Laboratory Services
  • 4.3.5 Outsourcing Services
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Molecular Diagnostics
  • 4.4.2 Immunoassays
  • 4.4.3 Microbial Culture
  • 4.4.4 Mass Spectrometry
  • 4.4.5 Next-Generation Sequencing
  • 4.4.6 Polymerase Chain Reaction (PCR)
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Data Collection Tools
  • 4.5.2 Data Analysis Tools
  • 4.5.3 Reporting Tools
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Clinical Diagnostics
  • 4.6.2 Drug Discovery and Development
  • 4.6.3 Public Health Surveillance
  • 4.6.4 Epidemiological Studies
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Hospitals and Clinics
  • 4.7.2 Diagnostic Laboratories
  • 4.7.3 Pharmaceutical Companies
  • 4.7.4 Research Institutes
  • 4.7.5 Government Agencies
  • 4.7.6 Veterinary Clinics
• 4.8 Market Size & Forecast by Solutions (2020-2035)
  • 4.8.1 Integrated Surveillance Systems
  • 4.8.2 Standalone Solutions
  • 4.8.3 Cloud-based Solutions
  • 4.8.4 On-premise Solutions
• 4.9 Market Size & Forecast by Deployment (2020-2035)
  • 4.9.1 Cloud
  • 4.9.2 On-Premises
  • 4.9.3 Hybrid

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 End User
    • 5.2.1.8 Solutions
    • 5.2.1.9 Deployment
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 End User
    • 5.2.2.8 Solutions
    • 5.2.2.9 Deployment
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 End User
    • 5.2.3.8 Solutions
    • 5.2.3.9 Deployment
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 End User
    • 5.3.1.8 Solutions
    • 5.3.1.9 Deployment
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 End User
    • 5.3.2.8 Solutions
    • 5.3.2.9 Deployment
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 End User
    • 5.3.3.8 Solutions
    • 5.3.3.9 Deployment
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 End User
    • 5.4.1.8 Solutions
    • 5.4.1.9 Deployment
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 End User
    • 5.4.2.8 Solutions
    • 5.4.2.9 Deployment
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 End User
    • 5.4.3.8 Solutions
    • 5.4.3.9 Deployment
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 End User
    • 5.4.4.8 Solutions
    • 5.4.4.9 Deployment
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 End User
    • 5.4.5.8 Solutions
    • 5.4.5.9 Deployment
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 End User
    • 5.4.6.8 Solutions
    • 5.4.6.9 Deployment
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 End User
    • 5.4.7.8 Solutions
    • 5.4.7.9 Deployment
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 End User
    • 5.5.1.8 Solutions
    • 5.5.1.9 Deployment
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 End User
    • 5.5.2.8 Solutions
    • 5.5.2.9 Deployment
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 End User
    • 5.5.3.8 Solutions
    • 5.5.3.9 Deployment
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 End User
    • 5.5.4.8 Solutions
    • 5.5.4.9 Deployment
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 End User
    • 5.5.5.8 Solutions
    • 5.5.5.9 Deployment
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 End User
    • 5.5.6.8 Solutions
    • 5.5.6.9 Deployment
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 End User
    • 5.6.1.8 Solutions
    • 5.6.1.9 Deployment
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 End User
    • 5.6.2.8 Solutions
    • 5.6.2.9 Deployment
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 End User
    • 5.6.3.8 Solutions
    • 5.6.3.9 Deployment
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 End User
    • 5.6.4.8 Solutions
    • 5.6.4.9 Deployment
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 End User
    • 5.6.5.8 Solutions
    • 5.6.5.9 Deployment

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 bioMerieux
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Thermo Fisher Scientific
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Luminex Corporation
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Alere Inc
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 OpGen
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Accelerate Diagnostics
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Meridian Bioscience
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 T2 Biosystems
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Mobidiag
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Becton Dickinson
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Roche Diagnostics
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Siemens Healthineers
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Bruker Corporation
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Qiagen
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Abbott Laboratories
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us